Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoshiko Takata
Increase in CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients and Its Impact on Prognosis
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Related publications
Identification of CD4+CD25+CD127− Regulatory T Cells and CD14+HLA−DR−/low Myeloid-Derived Suppressor Cells and Their Roles in the Prognosis of Breast Cancer
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Targeting Myeloid-Derived Suppressor Cells in the Treatment of Hepatocellular Carcinoma: Current State and Future Perspectives
Journal of Hepatocellular Carcinoma
O8: CD14+ CD33+ HLA-DR- Monocytic-Myeloid Derived Suppressor Cells (M-SCs) Recruited and Activated by CCR9/CCL25 Is Crucial for Pathogenic Progression of Endometriosis
American Journal of Reproductive Immunology
Gynecology
Reproductive Medicine
Immunology
Obstetrics
Allergy
Myeloid-Derived Suppressor Cells Correlate With Patient Outcomes in Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
CD14+ Regulatory Dendritic Cells in Patients With Hepatocellular Carcinoma and Cirrhosis
Hepatology
Medicine
Hepatology
Regulation of Accumulation and Function of Myeloid Derived Suppressor Cells in Different Murine Models of Hepatocellular Carcinoma
Journal of Hepatology
Hepatology
Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Low Levels of Tumor Suppressor Candidate 3 Predict Poor Prognosis of Patients With Hepatocellular Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Myeloid-Derived Suppressor Cells in Autoimmune Diseases
Inflammation and Regeneration
Allergy
Immunology
